Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jose Alvarez-Cardona"'
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 49, Iss , Pp 101304- (2023)
Background: Myeloproliferative neoplasms (MPNs) are chronic leukemias associated with increased risk of cardiovascular (CV) events. Prior studies suggest patients with MPN are at increased risk of HF. Additionally, pre-clinical murine models harborin
Externí odkaz:
https://doaj.org/article/dbb3fc9045b24469b179c3e022d8e4e1
Autor:
Kathleen W. Zhang, MD, Jennifer Miao, MD, Joshua D. Mitchell, MD, Jose Alvarez-Cardona, MD, Kelsey Tomasek, BS, Yan Ru Su, MD, Mary Gordon, RN, R. Frank Cornell, MD, Daniel J. Lenihan, MD
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 1, Pp 56-66 (2020)
Objectives: This study determined the diagnostic and prognostic usefulness of hepatocyte growth factor (HGF) in light chain and transthyretin cardiac amyloidosis. Background: Delays in diagnosis of cardiac amyloidosis are common, usually resulting fr
Externí odkaz:
https://doaj.org/article/48a556f3d56349a59bfad4103b1051a1
Autor:
Srilakshmi Vallabhaneni, Henning Steen, Jose Alvarez-Cardona, Daniel J. Lenihan, Joshua D. Mitchell, Kathleen W. Zhang, Pamela K. Woodard
Publikováno v:
The International Journal of Cardiovascular Imaging. 37:3003-3017
The purpose of this review is to provide an overview of the essential role that cardiovascular magnetic resonance (CMR) has in the field of cardio-oncology. Recent findings: CMR has been increasingly used for early identification of cancer therapy re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0172f549d33ae7def961e69ed19c3e8
https://doi.org/10.1007/s10554-021-02271-7
https://doi.org/10.1007/s10554-021-02271-7
Autor:
John Gorcsan, George A. Heberton, Peter Huntjens, Brian A. Van Tine, Joshua D. Mitchell, Peter Oppelt, Jose Alvarez-Cardona, Ronald J. Krone, Michele Landeau, Richa Rathore, Fei Wan, Justin M. Vader, Angela C. Hirbe, Kathleen W. Zhang, Yoku Soyama, Daniel J. Lenihan, Shellie Berry, Ashley Frith
Publikováno v:
Clinical Cancer Research. 27:3854-3860
Purpose: To report the interim analysis of the phase II single-arm noninferiority trial, testing the upfront use of dexrazoxane with doxorubicin on progression-free survival (PFS) and cardiac function in soft-tissue sarcoma (STS). Patients and Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d8a6c0d9f6822b7f351310021eb14b4
https://doi.org/10.1158/1078-0432.ccr-20-4621
https://doi.org/10.1158/1078-0432.ccr-20-4621
Autor:
Kathleen W. Zhang, Jose Alvarez-Cardona, Daniel J. Lenihan, Michael J. Fisch, Vlad G. Zaha, Joshua D. Mitchell
Publikováno v:
JACC: CardioOncology. 2:791-794
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ab772e071affb124982410b826d3498
https://doi.org/10.1016/j.jaccao.2020.08.014
https://doi.org/10.1016/j.jaccao.2020.08.014
Publikováno v:
Cardiology Clinics. 37:355-363
Anthracyclines have proved to be one of the most effective chemotherapeutic agents in the treatment of numerous solid tumors and hematologic malignancies in both adult and pediatric patients. Their clinical benefit, however, is sometimes hampered by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7620bd750d14ac91045cbfa428c0deb3
https://doi.org/10.1016/j.ccl.2019.08.001
https://doi.org/10.1016/j.ccl.2019.08.001
Publikováno v:
Atlas of Imaging in Cardio-Oncology ISBN: 9783030709976
A dramatic number of new therapies have developed over the past decade for the treatment of multiple myeloma (MM) and those treatments have resulted in substantial improvement in patient outcomes. Proteasome inhibitors (PI) are one such class of ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c2cf8ced4702a0bf9ce462dfb7e5e7d
https://doi.org/10.1007/978-3-030-70998-3_10
https://doi.org/10.1007/978-3-030-70998-3_10
Autor:
Srilakshmi Vallabhaneni, Ronald J. Krone, Joshua D. Mitchell, Kathleen W. Zhang, Daniel J. Lenihan, Jose Alvarez-Cardona
Publikováno v:
The American journal of medicine. 134(5)
Cardiac amyloidosis is increasingly recognized as an underdiagnosed cause of heart failure. Diagnostic delays of up to 3 years from symptom onset may occur, and patients may be evaluated by more than 5 specialists prior to receiving the correct diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8df424300ca3a907f8e89ade23c5ae
https://pubmed.ncbi.nlm.nih.gov/33444590
https://pubmed.ncbi.nlm.nih.gov/33444590
Autor:
Jordan Ray, Anita Arnold, Joseph R. Carver, Keith Stockerl-Goldstein, Jose Alvarez-Cardona, Eric H. Yang, Daniel J. Lenihan, Vlad G. Zaha, Joerg Herrmann, Joshua D. Mitchell, Susan Dent, Richard Cheng, Ana Barac, Monica Leja, Lavanya Kondapalli, Sherry-Ann Brown
Publikováno v:
Journal of the American College of Cardiology, vol 76, iss 19
The innovative development of cancer therapies has led to an unprecedented improvement in survival outcomes and a wide array of treatment-related toxicities, including those that are cardiovascular in nature. Aging of the population further adds to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c9abc513397084500f764811d65ca00
https://escholarship.org/uc/item/97c1h63x
https://escholarship.org/uc/item/97c1h63x
Autor:
Daniel J. Lenihan, Rupal O'Quinn, Stephen J. Casselli, Anne H. Blaes, Sameed M. Khatana, Srinath Adusumalli, Jose Alvarez-Cardona, Joshua D. Mitchell
Publikováno v:
Journal of cardiovascular translational research. 13(3)
The burgeoning field of cardio-oncology (C-O) is now necessary for the delivery of excellent care for patients with cancer. Many factors have contributed to this increasing population of cancer survivors or those being treated with novel and targeted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acc89058e99d7958296a47b8d6847b74
https://pubmed.ncbi.nlm.nih.gov/32444945
https://pubmed.ncbi.nlm.nih.gov/32444945